Why the study?
Does combined pre-procedural physiological assessment of vessel μQFR and diffuseness of CAD identify patients who will benefit most from PCI?
Does combined pre-procedural physiological assessment of vessel μQFR and diffuseness of CAD identify patients who will benefit most from PCI?
Combined pre-procedural physiological assessment of vessel μQFR and diffuseness of CAD may potentially identify patients who will benefit most from PCI.
Answers are grounded in this paper and cite their sources.
Geographic disparities warrant caution in generalizing PCI decisions; leaves open whether combined μQFR and CAD diffuseness assessment identifies optimal candidates.
There was geographic disparity in pre-procedural angiography-based pathophysiological characteristics. The combined pre-procedural physiological assessment of vessel μQFR and diffuseness of CAD may potentially identify patients who will benefit most from PCI.
No takes yet. Share an insight, caveat, or question.
Kotoku et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: